Skip to main content
Suzanne Oparil, MD, Cardiology, Birmingham, AL, University of Alabama Hospital

SuzanneOparilMD

Cardiology Birmingham, AL

Professor, Medicine, University of Alabama School of Medicine

Dr. Oparil is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Oparil's full profile

Already have an account?

Summary

  • Director, Vascular Biology & Hypertension Program

Education & Training

  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 1969 - 1970
  • Boston University Medical Center
    Boston University Medical CenterResidency, Internal Medicine, 1968 - 1969
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 1967 - 1968
  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1965 - 1967
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 1965

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 1971 - Present
  • AL State Medical License
    AL State Medical License 1977 - 2023
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2004-2014
  • Women's Health Castle Connolly, 2008
  • Men's Health Castle Connolly, 2007
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Concordance Between Blood Pressure in the Systolic Blood Pressure Intervention Trial and in Routine Clinical Practice  
    Suzanne Oparil, Mark A Parkulo, Priscilla Pemu, Paul K Whelton, JAMA Internal Medicine
  • Chlorthalidone and Hydrochlorothiazide for Treatment of Patients with Hypertension  
    Franz H Messerli, George C Roush, Suzanne Oparil, JAMA Internal Medicine
  • PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINT  
    Udayan Y Bhatt, Clinton B Wright, Vasilios Papademetriou, Joachim H Ix, Michael G Shlipak, Alfred K Cheung, Mark J Sarnak, Jing Chen, Charles Ginsberg, Glenn M Chertow..., Journal of the American Society of Nephrology
  • Join now to see all

Lectures

  • Hypertension Treatment in the Era of Precision Medicine 
    2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019

Authored Content

  • Chlorthalidone and Hydrochlorothiazide for Treatment of Patients with HypertensionJune 2020

Press Mentions

  • David Sibley, MD Began His Career with a Diagnostic Breakthrough
    David Sibley, MD Began His Career with a Diagnostic BreakthroughFebruary 21st, 2023
  • Endothelin Receptor Antagonist Effective in Resistant Hypertension: PRECISION
    Endothelin Receptor Antagonist Effective in Resistant Hypertension: PRECISIONNovember 9th, 2022
  • AHA 2022 – Idorsia and Cincor move forward in hypertension
    AHA 2022 – Idorsia and Cincor move forward in hypertensionNovember 8th, 2022
  • Join now to see all

Professional Memberships

Hospital Affiliations